PuSH - Publikationsserver des Helmholtz Zentrums München

Schoen, M.P.* ; Berking, C.* ; Biedermann, T.* ; Buhl, T.* ; Erpenbeck, L.* ; Eyerich, K.* ; Eyerich, S. ; Ghoreschi, K.* ; Goebeler, M.* ; Ludwig, R.J.* ; Schaekel, K.* ; Schilling, B.* ; Schlapbach, C.* ; Stary, G.* ; von Stebut, E.* ; Steinbrink, K.*

COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.

J. Dtsch. Dermatol. Ges. 18, 795-807 (2020)
Verlagsversion DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
The COVID-19 pandemic caused by SARS-CoV-2 has far-reaching direct and indirect medical consequences. These include both the course and treatment of diseases. It is becoming increasingly clear that infections with SARS-CoV-2 can cause considerable immunological alterations, which particularly also affect pathogenetically and/or therapeutically relevant factors. Against this background we summarize here the current state of knowledge on the interaction of SARS-CoV-2/COVID-19 with mediators of the acute phase of inflammation (TNF, IL-1, IL-6), type 1 and type 17 immune responses (IL-12, IL-23, IL-17, IL-36), type 2 immune reactions (IL-4, IL-13, IL-5, IL-31, IgE), B-cell immunity, checkpoint regulators (PD-1, PD-L1, CTLA4), and orally druggable signaling pathways (JAK, PDE4, calcineurin). In addition, we discuss in this context non-specific immune modulation by glucocorticosteroids, methotrexate, antimalarial drugs, azathioprine, dapsone, mycophenolate mofetil and fumaric acid esters, as well as neutrophil granulocyte-mediated innate immune mechanisms. From these recent findings we derive possible implications for the therapeutic modulation of said immunological mechanisms in connection with SARS-CoV-2/COVID-19. Although, of course, the greatest care should be taken with patients with immunologically mediated diseases or immunomodulating therapies, it appears that many treatments can also be carried out during the COVID-19 pandemic; some even appear to alleviate COVID-19.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
Schlagwörter Neutrophil Extracellular Traps; Cytokine Storm; Checkpoint Blockade; Mycophenolic-acid; Coronavirus; Pathogenesis; Chloroquine; Infections; Thrombosis; Pneumonia
ISSN (print) / ISBN 1610-0379
e-ISSN 1610-0387
Zeitschrift Journal der Deutschen Dermatologischen Gesellschaft
Quellenangaben Band: 18, Heft: 8, Seiten: 795-807 Artikelnummer: , Supplement: ,
Verlag Blackwell
Verlagsort Chichester
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)